Cardiff Oncology gugat Nerviano atas sengketa lisensi onvansertib

Reuters2026/08/11 20:23

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Cardiff Oncology Inc. menggugat Nerviano Medical Sciences di Pengadilan Distrik AS Distrik Selatan California pada Mei 2026.
Gugatan meminta putusan deklaratif bahwa Cardiff tidak melanggar perjanjian lisensi, serta perintah agar NMS tetap menjalankan kewajibannya.
Sengketa muncul setelah NMS mengirim pemberitahuan tertulis pada Februari 2026 yang menuduh pelanggaran material dan menyatakan pemutusan lisensi.
Cardiff menilai pemutusan itu tidak sah dan berencana tetap melanjutkan pelaksanaan perjanjian lisensi.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardiff Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-344645), on August 11, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Cardiff Oncology gugat Nerviano atas sengketa lisensi onvansertib

You may also like

Crypto prices